Vector Science and Therapeutics Corp. develops and sells novel biomechanical devices and active localized drug-delivery platforms. The company offers products and services based on its Smart, Steered, and Sustained framework for site-direct…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-08-26
Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options
News release - English.pdf
News 2026-08-24
Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online
News release - English.pdf
News 2026-08-20
Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides
News release - English.pdf
News 2026-08-18
Verlytix Launches as a Related Company to LyoGenesis Manufacturing
News release - English.pdf
News 2026-08-17
Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement with LyoGenesis Holdings
News release - English.pdf
Transactions 2026-07-28 M&A
Vector Science & Therapeutics Corp., LyoGenesis Plus and Wynn Pharmaceuticals Announce Strategic Collaboration to Develop and Manufacture Critical Care Medical Products
News release - English.pdf
Ownership 2026-07-25
Kelly, Scott bought +$50k
Insider trading – 2026-07-25
1 insider · +$50k net
Results 2026-07-24
Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28
News release - English.pdf
Results 2026-07-24
Interim MD&A - English.pdf
Results 2026-07-24
Interim financial statements/report letter from foreign issuer.pdf
News 2026-07-21
Vector Science & Therapeutics Announces Distributor Network Buildout to Support Its Peptide Portfolio Across Orthopedic, Sports, and Regenerative Medicine Channels
News release - English.pdf
News 2026-07-17
Vector Science & Therapeutics and Caresyntax Announce Real-World Evidence Partnership for VectorMist
News release - English.pdf
News 2026-07-15
News release - English.pdf
Ownership 2026-07-13
Dobranowski, Alexander Julian bought +$4k
Insider trading – 2026-07-13
1 insider · +$4k net
News 2026-07-07
Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio
News release - English.pdf
News 2026-06-30
News release - English.pdf
Transactions 2026-05-13 M&A
Vector Science & Therapeutics Agrees to an Option to Invest in LyoGenesis Plus, Securing Long-Term Access to FDA-Registered, cGMP Manufacturing
News release - English.pdf
Transactions 2026-05-11 M&A
Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group LLC
News release - English.pdf
Results 2026-05-04
Interim MD&A - English.pdf
Results 2026-05-04
Interim financial statements/report – English.pdf
Results 2026-05-04
Financial statements of RTO acquirer.pdf
News 2026-05-01
Vector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery
News release - English.pdf
Ownership 2026-04-24
Other securityholders documents - English.pdf
Transactions 2026-04-24 M&A
Vector Science and Therapeutics Corp. Announces Completion of Qualifying Transaction and Name Change
Material change report - English.pdf
Transactions 2026-04-24 Financing
Material document(s).pdf
Transactions 2026-04-14 M&A
OpenSesame Announces Entering Into Acquisition Agreement and Filing of Filing Statement for Qualifying Transaction
News release - English.pdf
Results 2026-04-11
Annual MD&A - English.pdf
Results 2026-04-11
Audited annual financial statements – English.pdf
Transactions 2026-03-17 Financing
OpenSesame Provides Update on the Terms of the Subscription Receipt Offering
News release - English.pdf
Results 2025-12-02 Financials
Interim financial statements/report – English.pdf
Results 2025-12-02 Financials
Interim MD&A - English.pdf
News 2025-11-25
Other.pdf
News 2025-11-25
Other.pdf
News 2025-10-06
News release - English.pdf
Results 2025-08-29 Financials
Interim MD&A - English.pdf
Results 2025-08-29 Financials
Interim financial statements/report – English.pdf